San Diego Business Journal

SD HEALTHCARE

Recent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...
Tease photo

BioMed Realty and Broad Institute Form Strategic Partnership to Promote Innovation

San Diego-based BioMed Realty Trust Inc. and the Broad Institute of MIT and Harvard announced a strategic partnership to foster innovation and promote relationships between academia and the life science industry.

Tease photo

Chargers Blood Drive Set for November 25

The 36th annual Chargers Blood Drive, sponsored by San Diego County Credit Union, will be held on Tuesday, Nov. 25 from 9 a.m. to 6 p.m. at the Town and Country Resort Hotel & Convention Center in Mission Valley.

PsychArmor Gets $1 Million Donation to Open Center

PsychArmor, a nonprofit that helps veterans and their families, recently received a $1 million donation from the Rebecca Moores Foundation. The grant will help launch the Moores Center for Military Service Providers, which will assist civilian mental health practitioners who care for veterans, as well as others who provide similar services.

Organovo Releases Commercial Version of 3D Liver Tissue

Organovo Holdings Inc., a company that creates human tissues by 3-D bioprinting, announced the release of a commercial version of its bioprinted human liver tissue, specifically designed for testing drug toxicity.

ResMed's Sleep-Monitoring Device Now Available at Apple Stores

ResMed Inc., a San Diego-based company that develops medical devices for sleep apnea and other sleep-related breathing disorders, announced that its newest sleep-monitoring device will be available through Apple retail stores in the United States and from the Apple Online Store.

Agreement Gives Human Longevity Inc. Access to Major Database

San Diego-based Human Longevity Inc., a biological data-driven human health technology and cell therapy company, announced a collaborative agreement with King’s College London to access its TwinsUK Registry.

RecoveryWorks Offers Treatment Program for Professionals

RecoveryWorks, a new intensive outpatient treatment program for the treatment of alcoholism and addiction, is open and accepting patients, according to its founder, Clark Smith.

Pathway Genomics Corp. Partners With Online Registry

Pathway Genomics Corp., a San Diego-based clinical laboratory that offers genetic testing services globally, announced that it has partnered with the Prospective Registry of Multiplex Testing (PROMPT), an online registry for patients who have undergone testing for cancer-causing genetic mutations.

Breast Cancer Study Finds Pluses in Use of Proton Therapy

Despite its reputation for being expensive, proton cancer therapy may cost the same or less than other cancer therapies, according to a recent study using Medicare reimbursement codes.

Otonomy Inc. Reports Increased R&D Expenses in Q3

San Diego-based Otonomy Inc., a clinical-stage biopharmaceutical company developing treatments for the inner and middle ear, announced financial results for the third quarter of 2014.

Health Care Reset Button Will Get Pushed, But Not all the Way

While the election results ensure a new round of attacks on Obamacare, experts say a full repeal of the federal health care law is, well, impossible.

Tease photo

S.D. Firms Tackle Symptoms, Ebola Diagnostics

MEDICINE: The Cos. Have the Capacity for Ramping Up Production

Another San Diego-based company is taking aim at Ebola, but unlike the other companies, Leading BioSciences Inc. is focusing on treating the symptoms of the deadly virus rather than targeting the virus itself.

Receptos CEO Named Chairman of Tocagen's Board of Directors

Tocagen Inc., a clinical-stage company working on therapies that boost the immune response to cancer, announced that Faheem Hasnain, president and chief executive officer of Receptos Inc., has been appointed as chairman of the board of directors.

Sophiris Bio Inc. Reports Third Quarter Results

La Jolla-based Sophiris Bio Inc., a clinical stage biopharmaceutical company developing products for the treatment of urological diseases, announced its third quarter financial results.

Pfenex Inc. Reports Q3 Revenue of $2.8 Million

Pfenex Inc., a clinical-stage biotechnology company that makes biosimilars, including vaccines for anthrax and malaria, reported financial results for the third quarter that ended Sept. 30, 2014.